| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |